Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijayakumar Velu

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Current Opinion in HIV and AIDS|January 8, 2025
Role of follicular homing natural killer cells in HIV infectionSivasankaran Munusamy Ponnan, Sakthivel Govindaraj, Vijayakumar Velu
World Journal of Gastroenterology|May 7, 2015
Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel diseaseRaghavan Chinnadurai, Spencer Ng, Vijayakumar Velu, et al.
World Journal of Virology|February 13, 2015
Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infectionEsaki M Shankar, Vijayakumar Velu, Adeeba Kamarulzaman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infectionPragati Nigam, Suefen Kwa, Vijayakumar Velu, et al.
Frontiers in Immunology|June 22, 2018
Tfh1 Cells in Germinal Centers During Chronic HIV/SIV InfectionVijayakumar Velu, Geetha Mylvaganam, Chris Ibegbu, et al.
Retrovirology|March 11, 2015
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic optionsVijayakumar Velu, Ravi Dyavar Shetty, Marie Larsson, et al.
Current Infectious Disease Reports|February 11, 2011
Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 InfectionEsaki Muthu Shankar, Pachamuthu Balakrishnan, Ramachandran Vignesh, et al.
World Journal of Gastroenterology|June 26, 2007
Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in IndiaVijayakumar Velu, Subhadra Nandakumar, Saravanan Shanmugam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2010
Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral controlPragati Nigam, Vijayakumar Velu, Sunil Kannanganat, et al.
Microbiology and Immunology|August 21, 2012
Recent advances targeting innate immunity-mediated therapies against HIV-1 infectionEsaki Muthu Shankar, Vijayakumar Velu, Ramachandran Vignesh, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Current Opinion in HIV and AIDS|January 8, 2025
Role of follicular homing natural killer cells in HIV infectionSivasankaran Munusamy Ponnan, Sakthivel Govindaraj, Vijayakumar Velu
World Journal of Gastroenterology|May 7, 2015
Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel diseaseRaghavan Chinnadurai, Spencer Ng, Vijayakumar Velu, et al.
World Journal of Virology|February 13, 2015
Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infectionEsaki M Shankar, Vijayakumar Velu, Adeeba Kamarulzaman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infectionPragati Nigam, Suefen Kwa, Vijayakumar Velu, et al.
Frontiers in Immunology|June 22, 2018
Tfh1 Cells in Germinal Centers During Chronic HIV/SIV InfectionVijayakumar Velu, Geetha Mylvaganam, Chris Ibegbu, et al.
Retrovirology|March 11, 2015
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic optionsVijayakumar Velu, Ravi Dyavar Shetty, Marie Larsson, et al.
Current Infectious Disease Reports|February 11, 2011
Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 InfectionEsaki Muthu Shankar, Pachamuthu Balakrishnan, Ramachandran Vignesh, et al.
World Journal of Gastroenterology|June 26, 2007
Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in IndiaVijayakumar Velu, Subhadra Nandakumar, Saravanan Shanmugam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2010
Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral controlPragati Nigam, Vijayakumar Velu, Sunil Kannanganat, et al.
Microbiology and Immunology|August 21, 2012
Recent advances targeting innate immunity-mediated therapies against HIV-1 infectionEsaki Muthu Shankar, Vijayakumar Velu, Ramachandran Vignesh, et al.
Pageof 11